Skip to main content
SpringerLink
Log in

Distribution of the type III effector proteins-encoding genes among nosocomial Pseudomonas aeruginosa isolates from Bulgaria

  • Original paper
  • Published:
Annals of Microbiology Aims and scope Submit manuscript

Abstract

The aim of this study was to determine the prevalence of type III effector proteins (ExoS, ExoU, ExoT and ExoY)-encoding genes among clonally unrelated nosocomial Pseudomonas aeruginosa strains and to analyze their distribution in respect to the infection site and antimicrobial resistance. Polymerase chain reaction-based detection of the genes was performed on 176 non-duplicate P. aeruginosa isolates from three University hospitals in Sofia, previously genotyped by random amplified polymorphic DNA technique. The prevalence of the studied genes was as follows: exoS–61.9%, exoU–32.4%, exoT–100%, and exoY–85.8%. The part of P. aeruginosa strains harboring either the exoS (54.0%) or the exoU (23.8%) gene was higher (P < 0.001) than that of isolates containing both genes (8.5%). The gene dissemination varied according to the infection localization. The exoU gene manifested a higher spread (P < 0.001) among multidrug-resistant (MDR) than in non-MDR strains (42.6 vs 18.7%). In conclusion, the P. aeruginosa type III secretion system is present in nearly all studied isolates but the individual isolates from distinct infection sites differ in their effector genotypes. The ubiquity of type III effector proteins-encoding genes among clinical isolates is consistent with an important role for this system in P. aeruginosa pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Allewelt M, Coleman FT, Grout M, Priebe GP, Pier GB (2000) Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect Immun 68:3998–4004

    Article  CAS  PubMed  Google Scholar 

  • Berthelot P, Attree I, Plésiat P, Chabert J, de Bentzmann S, Pozzetto B, Grattard F, the Groupe d’Etudes des Septicémies à Pseudomonas aeruginosa (2003) Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J Infect Dis 188:512–518

    Article  CAS  PubMed  Google Scholar 

  • Blanc DS, Petignat C, Janin B, Bille J, Francioli P (1998) Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. Clin Microbiol Infect 4:242–247

    Article  PubMed  Google Scholar 

  • CLSI (2007) Performance standards for antimicrobial susceptibility testing, 17th informational supplement, M100-S17. Clinical and Laboratory Standards Institute, Wayne

    Google Scholar 

  • Di Martino P, Gagniere H, Berry H, Bret L (2002) Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparison with imipenem-resistant extra-respiratory tract isolates from uninfected patients. Microbes Infect 4:613–620

    Article  PubMed  Google Scholar 

  • Engel J, Balachandran P (2009) Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 12:61–66

    Article  CAS  PubMed  Google Scholar 

  • Feltman H, Schulert G, Khan S, Jain M, Peterson L, Hauser AR (2001) Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147:2659–2669

    CAS  PubMed  Google Scholar 

  • Finck-Barbancon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, Fleiszig SM, Wu C, Mende-Mueller L, Frank DW (1997) ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 25:547–557

    Article  CAS  PubMed  Google Scholar 

  • Finnan S, Morrissey JP, O’Gara F, Boyd EF (2004) Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol 42:5783–5792

    Article  CAS  PubMed  Google Scholar 

  • Garey KW, Vo QP, Larocco MT, Gentry LO, Tam VH (2008) Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia. J Chemother 20:714–720

    CAS  PubMed  Google Scholar 

  • Goehring UM, Schmidt G, Pedersen KJ, Aktories K, Barbieri JT (1999) The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem 274:36369–36372

    Article  CAS  PubMed  Google Scholar 

  • Hauser A (2009) The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7:654–665

    Article  CAS  PubMed  Google Scholar 

  • Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J (2002) Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 30:521–528

    Article  CAS  PubMed  Google Scholar 

  • Kirikae T, Mizuguchi Y, Arakawa Y (2008) Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan. J Antimicrob Chemother 61:612–615

    Article  CAS  PubMed  Google Scholar 

  • Krall R, Schmidt G, Aktories K, Barbieri JT (2000) Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect Immun 68:6066–6068

    Article  CAS  PubMed  Google Scholar 

  • Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP (1999) Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 104:743–750

    Article  CAS  PubMed  Google Scholar 

  • Lanotte P, Watt S, Mereghetti L, Dartiguelongue N, Rastegar-Lari A, Goudeau A, Quentin R (2004) Genetic feature of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J Med Microbiol 53:73–81

    Article  CAS  PubMed  Google Scholar 

  • Lomholt JA, Poulsen K, Kilian M (2001) Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun 69:6284–6295

    Article  CAS  PubMed  Google Scholar 

  • Nicas TI, Bradley J, Lochner JE, Iglewski BH (1985a) The role of exoenzyme S in infections with Pseudomonas aeruginosa. J Infect Dis 152:716–721

    CAS  PubMed  Google Scholar 

  • Nicas TI, Frank DW, Stenzel P, Lile JD, Iglewski BH (1985b) Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections. Eur J Clin Microbiol 4:175–179

    Article  CAS  PubMed  Google Scholar 

  • Pagani L, Colinon C, Migliavacca R, Labonia M, Docquier JD, Nucleo E, Spalla M, Li Bergoli M, Rossolini GM (2005) Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-β-lactamase. J Clin Microbiol 43:3824–3828

    Article  CAS  PubMed  Google Scholar 

  • Phillips RM, Six DA, Dennis EA, Ghosh P (2003) In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J Biol Chem 278:41326–41332

    Article  CAS  PubMed  Google Scholar 

  • Pinheiro MRS, Lacerda HR, Melo RGL, Maciel MA (2008) Pseudomonas aeruginosa infections: factors relating to mortality with emphasis on resistance pattern and antimicrobial treatment. Braz J Infect Dis 12:509–515

    Article  PubMed  Google Scholar 

  • Pirnay J-P, Bilocq F, Pot B, Cornelis P, Zizi M, Van Eldere J, Deschaght P, Vaneechoutte M, Jennes S, Pitt T, De Voss D (2009) Pseudomonas aeruginosa population structure revisited. PLoS ONE 4:e7740. doi:10.1371/journal.pone.0007740

    Article  PubMed  Google Scholar 

  • Rajan S, Saiman L (2002) Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 17:47–56

    Article  PubMed  Google Scholar 

  • Schulert GS, Feltman H, Rabin SD, Martin CG, Battle SE, Rello J, Hauser AR (2003) Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis 188:1695–1706

    Article  CAS  PubMed  Google Scholar 

  • Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, Fujino T, Kikuchi H, Sasaki S, Watari H, Kojima T, Miki H, Kanemitsu K, Kunishima H, Kikuchi Y, Kaku M, Yoshikura H, Kuratsuji T, Kirikae T (2007) Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 45:979–989

    Article  CAS  PubMed  Google Scholar 

  • Stover CK, Pham XQ, Erwin AL et al (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959–964

    Article  CAS  PubMed  Google Scholar 

  • Strateva T (2008) Microbiological and molecular-genetic investigations on resistance mechanisms and virulence factors in clinical strains of Pseudomonas aeruginosa. PhD dissertation, Medical University of Sofia, Bulgaria

  • Tamura M, Ajayi T, Allmond LR, Moriyama K, Wiener-Kronish JP, Sawa T (2004) Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU. Biochem Biophys Res Commun 316:323–331

    Article  CAS  PubMed  Google Scholar 

  • Vallis AJ, Fink-Barbacon V, Yahr TL, Frank DW (1999) Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect Immun 67:2040–2044

    CAS  PubMed  Google Scholar 

  • Van Delden C, Iglewski BH (1998) Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 4:551–560

    Article  PubMed  Google Scholar 

  • Wang CY, Jerng JS, Cheng KY, Lee LN, Yu CJ, Hsueh PR, Yang PC (2006) Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes. Clin Microbiol Infect 12:63–68

    Article  CAS  PubMed  Google Scholar 

  • Winstanley C, Kaye SB, Neal TJ, Chilton HJ, Miksch S, Hart CA, Microbiology Ophthalmic Group (2005) Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J Med Microbiol 54:519–526

    Article  CAS  PubMed  Google Scholar 

  • Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW (1998) ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Natl Acad Sci USA 95:13899–13904

    Article  CAS  PubMed  Google Scholar 

  • Zaborina O, Kohler JE, Wang Y, Bethel C, Shevchenko O, Wu L, Turner JR, Alverdy JC (2006) Identification of multi-drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier. Ann Clin Microbiol Antimicrob 5:14

    Article  PubMed  Google Scholar 

  • Zhu H, Conibear TCR, Bandara R, Aliwarga Y, Stapleton F, Willcox MDP (2006) Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res 31:297–306

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This work was supported by a grant from the Medical University of Sofia (Council of Medical Science, project no. 4/2009, grant no. 20/2009).

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, Medical University of Sofia, 2 Zdrave str., 1431, Sofia, Bulgaria

    Tanya Strateva, Boyka Markova & Ivan Mitov

  2. Laboratory of Clinical Microbiology, Second Multiprofile Active Treatment Hospital, Sofia, Bulgaria

    Dobrinka Ivanova

Authors
  1. Tanya Strateva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Boyka Markova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dobrinka Ivanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ivan Mitov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tanya Strateva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strateva, T., Markova, B., Ivanova, D. et al. Distribution of the type III effector proteins-encoding genes among nosocomial Pseudomonas aeruginosa isolates from Bulgaria. Ann Microbiol 60, 503–509 (2010). https://doi.org/10.1007/s13213-010-0079-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13213-010-0079-3

Keywords

Search

Navigation